Jade Biosciences, Inc. (JBIO) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Jade Biosciences, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
High 17.20 at 2:30 pm ET, low 16.84 at 12:15 pm ET.
Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
the bull case· 3
153
managers reporting a position in thirteen f filings
13fJun 30 '26+15.16%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '263
of the funds on file reporting a position in JBIO
n-portas of Jun 30 '26the bear case· 2
3 of 19
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '260.32%
of State Street SPDR S P Biotech ETF's assets, largest fund weight on file
n-portJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 16 '26 report. Not a forecast, not advice.
Of the 6 companies Jade Biosciences, Inc. moves with most closely, none share its SEC classification.
Measured against 149 trading days of our own closes. Co-movement, not cause.
SIC 2834, Pharmaceutical Preparations, from each company's own filings. Largest first.
153 managers report a position worth $1.6B between them, and 23 of them hold 80% of it.
tall tick = annual report · 1 on record
JBIO (Jade Biosciences, Inc.) has 3 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.